178

Immunology & Rheumatology
Focuses on rheumatic and immune diseases.
Sub Categories on Immunology & Rheumatology
Latest Articles
Poverty tied to worse functional status in rheumatoid arthritis

Poverty tied to worse functional status in rheumatoid arthritis

(HealthDay)—Worse functional status and increased probability of functional decline are seen for patients with rheumatoid arthritis (RA) with lower socioeconomic status (SES), according to a study pub

Poverty tied to worse functional status in rheumatoid arthritis

(HealthDay)—Worse functional status and increased probability of functional decline are seen for patients with rheumatoid arthritis (RA) with lower socioeconomic status (SES), according to a study pub
Early and intensive treatment of rheumatoid arthritis reduces fatigue

Early and intensive treatment of rheumatoid arthritis reduces fatigue

by European League Against RheumatismCredit: CC0 Public DomainDisease-related, profound fatigue impairs the quality of life of many people with rheumatic and musculoskeletal diseases. A Belgian s

Early and intensive treatment of rheumatoid arthritis reduces fatigue

by European League Against RheumatismCredit: CC0 Public DomainDisease-related, profound fatigue impairs the quality of life of many people with rheumatic and musculoskeletal diseases. A Belgian s
Researchers link gut microbiome to rheumatoid arthritis prognosis

Researchers link gut microbiome to rheumatoid arthritis prognosis

by Susan Murphy,Mayo ClinicCredit: Pixabay/CC0 Public DomainA significant indicator of whether a patient with rheumatoid arthritis will improve over the course of disease may lie in part in thei

Researchers link gut microbiome to rheumatoid arthritis prognosis

by Susan Murphy,Mayo ClinicCredit: Pixabay/CC0 Public DomainA significant indicator of whether a patient with rheumatoid arthritis will improve over the course of disease may lie in part in thei
Weekly leflunomide effective for early rheumatoid arthritis

Weekly leflunomide effective for early rheumatoid arthritis

(HealthDay)—A higher, weekly dose of leflunomide shows similar benefits to a daily dose for the treatment of mild-to-moderate early rheumatoid arthritis (ERA), according to a study published online Au

Weekly leflunomide effective for early rheumatoid arthritis

(HealthDay)—A higher, weekly dose of leflunomide shows similar benefits to a daily dose for the treatment of mild-to-moderate early rheumatoid arthritis (ERA), according to a study published online Au
Genetic key to lupus shows potential of personalised medicine

Genetic key to lupus shows potential of personalised medicine

by Australian National UniversityDr Julia Ellyard(Medical Xpress)—Medical researchers have used DNA sequencing to identify a gene variant responsible for causing lupus in a young patient.The deve

Genetic key to lupus shows potential of personalised medicine

by Australian National UniversityDr Julia Ellyard(Medical Xpress)—Medical researchers have used DNA sequencing to identify a gene variant responsible for causing lupus in a young patient.The deve
Early drug intervention reduces risk of cardiovascular events in rheumatoid arthritis sufferers

Early drug intervention reduces risk of cardiovascular events in rheumatoid arthritis sufferers

by Rebecca Biason,University of TorontoCredit: CC0 Public DomainPeople who develop rheumatoid arthritis as older adults benefit from early and sustained use of a drug called Methotrexate (MTX),

Early drug intervention reduces risk of cardiovascular events in rheumatoid arthritis sufferers

by Rebecca Biason,University of TorontoCredit: CC0 Public DomainPeople who develop rheumatoid arthritis as older adults benefit from early and sustained use of a drug called Methotrexate (MTX),
Program may help patients with rheumatic diseases quit smoking

Program may help patients with rheumatic diseases quit smoking

by WileyCredit: CC0 Public DomainSmoking increases symptoms and health risks for patients with rheumatic diseases, but interventions to help patients quit are rarely available at rheumatology cli

Program may help patients with rheumatic diseases quit smoking

by WileyCredit: CC0 Public DomainSmoking increases symptoms and health risks for patients with rheumatic diseases, but interventions to help patients quit are rarely available at rheumatology cli
Race, ethnic disparities seen in age-adjusted prevalence of arthritis

Race, ethnic disparities seen in age-adjusted prevalence of arthritis

by Elana GotkineThe age-adjusted prevalence of arthritis varies by race and ethnicity, with higher prevalence seen among American Indian/Alaska Native adults, according to a studypublished

Race, ethnic disparities seen in age-adjusted prevalence of arthritis

by Elana GotkineThe age-adjusted prevalence of arthritis varies by race and ethnicity, with higher prevalence seen among American Indian/Alaska Native adults, according to a studypublished
Omega-3 fatty acid stops lupus trigger, but how?

Omega-3 fatty acid stops lupus trigger, but how?

by James Pestka , Sarina Gleason,Michigan State UniversityCredit: Michigan State UniversityMichigan State University scientists have received a $2.3 million, five-year National Institutes of Hea

Omega-3 fatty acid stops lupus trigger, but how?

by James Pestka , Sarina Gleason,Michigan State UniversityCredit: Michigan State UniversityMichigan State University scientists have received a $2.3 million, five-year National Institutes of Hea
Tofacitinib ups rheumatoid arthritis treatment response

Tofacitinib ups rheumatoid arthritis treatment response

The addition of tofacitinib to rheumatoid arthritis treatment regimens improves patient response to non-biologic disease-modifying antirheumatic drugs, according to a study published in the Aug. 20 is

Tofacitinib ups rheumatoid arthritis treatment response

The addition of tofacitinib to rheumatoid arthritis treatment regimens improves patient response to non-biologic disease-modifying antirheumatic drugs, according to a study published in the Aug. 20 is
T cells take the lead in controlling SARS-CoV-2 and reducing COVID-19 disease severity

T cells take the lead in controlling SARS-CoV-2 and reducing COVID-19 disease severity

by La Jolla Institute for ImmunologyA multi-layered, virus-specific immune response is important for controlling the virus during the acute phase of the infection and reducing COVID-19 disease se

T cells take the lead in controlling SARS-CoV-2 and reducing COVID-19 disease severity

by La Jolla Institute for ImmunologyA multi-layered, virus-specific immune response is important for controlling the virus during the acute phase of the infection and reducing COVID-19 disease se
How COVID-19 triggers massive inflammation

How COVID-19 triggers massive inflammation

by Children's Hospital BostonSARS-CoV-2 (shown here in an electron microscopy image). Credit: National Institute of Allergy and Infectious Diseases, NIHA study led by researchers at Boston Ch

How COVID-19 triggers massive inflammation

by Children's Hospital BostonSARS-CoV-2 (shown here in an electron microscopy image). Credit: National Institute of Allergy and Infectious Diseases, NIHA study led by researchers at Boston Ch